Clinical support materials


CLL Exchange Bite-sized: Cardiac comorbidity decision making in 1L CLL


Join Dr Renata Walewska discussing what guides decision making for CLL patients with cardiac comorbidities.

Found this useful? You might also be interested in:

 

CLL Exchange Bite-sized:
Fixed-duration decision
making in 1L CLL.

BSH Guidelines 2025
for the 1L Treatment of CLL

Adverse events should be reported

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by visiting contactazmedical.astrazeneca.com or by calling 0800 783 0033.

September 2025 I GB-69434